- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
- 10-K Annual report
- 10.39 Assignment of Agreement, Dated As of April 12, 2018, by and Among the University of Texas In Austin, on Behalf of the Board of Regents of the University of Texas, CBM Biopharma, Inc. and Spherix Incorporated
- 10.40 Assignment of Agreement, Dated As of April 17, 2018, by and Among Wake Forest University Health Sciences, CBM Biopharma, Inc. and Spherix Incorporated
- 21.1 List of Subsidiaries
- 23.1 Consent of Marcum LLP, Independent Registered Public Accounting Firm
- 31.1 Certification
- 32.1 Certification
- Download Excel data file
- View Excel data file
Exhibit 23.1
Independent Registered Public Accounting Firm’s Consent
We consent to the incorporation by reference in the Registration Statement of Spherix Incorporated (the “Company”) on Form S-8 (333-210627), Form S-8 (333-197429), Form S-8 (333-187811), Form S-8 (333-185524), Form S-3 (333-222488) and Form S-1 (333-236199), of our report, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, dated January 31, 2020, with respect to our audits of the consolidated financial statements of Spherix Incorporated and Subsidiaries as of December 31, 2019 and 2018 and for each of the two years in the period ended December 31, 2019, which report is included in this Annual Report on Form 10-K of Spherix Incorporated for the year ended December 31, 2019.
/s/ Marcumllp
Marcumllp
New York, NY
January 31, 2020